Should a 90-Year-Old Get a Pacemaker?

A pacemaker can be a reasonable and often beneficial procedure for a 90-year-old, provided the decision accounts for overall health rather than age alone. Multiple studies of nonagenarians (people aged 90 and older) consistently find that the procedure itself is safe, that symptom relief is substantial, and that the strongest predictors of poor outcomes after implantation are conditions like heart failure, kidney disease, and cancer rather than the number on the birthday cake. The question is less “is 90 too old?” and more “what is this particular person’s health picture, and will a pacemaker meaningfully improve their remaining life?”

Why the Procedure Happens at This Age

The heart’s electrical system deteriorates with age. By 90, many people develop heart rhythms that are dangerously slow, a condition broadly called bradycardia. The two most common reasons a nonagenarian ends up in the conversation about a pacemaker are atrioventricular block, where electrical signals between the upper and lower chambers of the heart are delayed or blocked, and symptomatic bradycardia causing fainting, dizziness, or heart failure. In a large single-center study of very elderly pacemaker recipients, roughly 57% received their device for atrioventricular block and 43% for other bradycardia-related symptoms.¹ A Japanese case series specifically of patients over 90 documented syncope and congestive heart failure tied to bradycardia as the primary triggers for implantation.²

These are not vague or optional indications. Syncope in a 90-year-old is a medical emergency: a single fall from a fainting spell can cause a hip fracture, a head injury, or a cascade of immobility that accelerates decline. When the underlying rhythm abnormality is correctable with a pacemaker, the alternative of leaving it untreated carries real and immediate risk.

How Safe Is the Procedure Itself?

One of the most persistent fears is that the surgery will be too much for someone this old. The data says otherwise, with an important caveat about context. A nationwide analysis of the U.S. inpatient database found that in-hospital mortality after pacemaker implantation was about 1.9% in patients over 90, compared with roughly 0.6% in patients aged 70 to 79. Complication rates were only modestly higher in the older group, around 6.3% versus 5.6%.³ Those numbers come from tens of thousands of cases, making them a solid benchmark.

A smaller but detailed study of 148 patients aged 80 and older reported zero complications during the procedure itself. Within 30 days, the overall complication rate was about 5.4%, and 30-day all-cause mortality was 2%. Cardiovascular-attributable mortality in that first month was under 1%.⁴ The most common complication across studies is pocket hematoma, essentially a bruise at the implant site, which is uncomfortable but rarely dangerous.⁵

The picture that emerges is that pacemaker implantation at 90 is not a trivial procedure, but it is also not the high-stakes gamble many families imagine. In-hospital death is uncommon, serious complications are in the single digits, and the procedure can typically be done under local anesthesia with light sedation. Research on sedation dosing in elderly pacemaker patients has shown that significantly lower doses of sedative drugs keep patients stable and comfortable, reducing the risks associated with general anesthesia.⁶

What Survival Actually Looks Like Afterward

Survival after pacemaker implantation in nonagenarians varies widely, and the variation has more to do with the patient’s other medical conditions than with the device. One study following 149 nonagenarians found a one-year survival rate of 70%, a three-year rate of about 35%, and a five-year rate of 10%. No long-term pacemaker-related complications were recorded during follow-up.⁷ Another study of nonagenarians who received pacemakers reported a 12-month mortality probability of about 25%.⁸

These numbers need context: average life expectancy at 90 is already limited regardless of heart rhythm. The critical question is whether having a pacemaker changes the mortality trajectory. A Canadian study compared nonagenarians who received pacemakers with age- and sex-matched controls who did not, and found that the risk of death did not differ significantly between the two groups after adjusting for demographics. The annual mortality rate in the pacemaker group was about 19%, and factors like a history of heart failure or stroke, not the pacemaker itself, were the significant predictors of who died sooner.⁵

That finding might sound disappointing until you realize what it means: the pacemaker group had a life-threatening rhythm problem that would have been expected to worsen their prognosis, yet they survived at the same rate as people without that problem. The device effectively neutralized the electrical threat. What it cannot do is reverse the other conditions that shorten life at this age.

What Predicts a Bad Outcome

If age alone is not the deciding factor, what is? Several studies converge on the same handful of conditions that flag higher risk. Active cancer was associated with a dramatically higher chance of death in one Italian study of nonagenarians, with a roughly five-fold increase, and neurological disease carried a similar elevation.⁸ Chronic kidney disease, heart failure, and longer hospital stays before the implant also emerged as predictors of earlier death in multiple analyses.⁷

Frailty deserves its own mention. A study of emergency pacemaker implantations in nonagenarians found that the Rockwood frailty score independently predicted mortality. Atrial fibrillation and a widened QRS complex on the electrocardiogram were also independent predictors. Frailer patients were more likely to receive a simpler single-chamber pacemaker, which in that study was itself associated with higher cardiac death after adjusting for frailty and other conditions.⁹ The implication is that frailty assessment should be part of the pre-implantation workup, and that how the device is chosen (single-chamber versus dual-chamber) matters in this population.

Symptom Relief and Fall Prevention

Where pacemakers arguably shine brightest in the very elderly is not in adding years of life but in making daily life safer and more functional. A population-based study of octogenarians and nonagenarians found that three out of four patients had a decrease in their symptoms after pacemaker implantation.¹⁰ Fainting stopped, dizziness eased, and for many, a source of daily misery was eliminated.

Falls are one of the biggest threats to independence at 90. When those falls are caused by a heart rhythm too slow to keep the brain properly supplied with blood, a pacemaker can be transformative. Research on elderly patients with sinus node dysfunction found that the proportion of patients experiencing at least one fall dropped by about 75% in the year after pacemaker implantation compared with the year before. Falls leading to fracture were eliminated entirely in that cohort.¹¹ A separate study confirmed the pattern, with the absolute number of falls reduced by 90% and falls requiring medical attention dropping from about 31% of patients to 8%.¹²

For a 90-year-old who is falling repeatedly because of syncope, the pacemaker is less about extending life and more about preventing the catastrophic injury that ends independence. A hip fracture at 90 often means permanent nursing home admission. Preventing it can be the difference between living at home and not.

Gender Differences in Nonagenarian Pacemaker Patients

Men and women arrive at pacemaker implantation differently at this age, even though outcomes end up similar. A recent study of 110 nonagenarian pacemaker recipients found that syncope was the most common presenting symptom in both sexes. However, women were much more likely to present with heart failure symptoms and fatigue, while men more often presented with dizziness or had no symptoms at all. Women also had significantly higher rates of frailty and advanced chronic kidney disease. Despite these differences, overall mortality during an average follow-up of about 14 months was comparable between men and women, roughly 27% versus 35% with no statistically significant gap.¹³

The takeaway is that the benefit of the device does not appear to favor one sex over another. Women tend to be frailer at the time of implantation, which means a careful frailty assessment is especially important, but frailty alone does not seem to negate the benefit.

Leadless Pacemakers for Very Old Patients

Traditional pacemakers involve leads (thin wires) threaded through veins into the heart, connected to a generator implanted under the skin near the collarbone. That generator pocket can get infected, and the leads can cause problems over time. In very elderly patients who are thin, have fragile skin, or have dementia and might unconsciously pick at the implant site, these are real concerns.¹⁴

Leadless pacemakers, which are self-contained capsules implanted directly inside the heart via a catheter through the leg vein, eliminate the pocket and the leads entirely. A study comparing leadless and traditional pacemakers in patients averaging about 90 years old found no difference in complication rates between the two approaches, but the leadless procedure was significantly faster, taking about 36 minutes on average compared with about 62 for the traditional approach.¹⁵ In nonagenarians specifically, the leadless Micra device was successfully implanted in about 98% of cases, with no device-related deaths, infections, or dislodgements during follow-up.¹⁶

A two-year follow-up case series also found that implanting a leadless pacemaker alongside an old, non-functional transvenous system, without the added risk of extracting the old generator, appeared safe and effective in extremely elderly patients.¹⁷ For patients who already have an older device that needs replacing, this avoids the complications of extraction surgery, which can be particularly risky in frail elderly patients with scarred-in leads.

The catch is that current leadless pacemakers are limited to single-chamber pacing. Patients who need dual-chamber pacing, for instance those with certain types of atrioventricular block, may still require a traditional system. But for the subset of nonagenarians who qualify, leadless devices represent a genuinely lower-hassle option.

The Role of Families and Shared Decision-Making

At 90, the pacemaker decision rarely happens in a vacuum. Family members are almost always involved, and their concerns often center on whether the procedure will cause suffering and whether it will meaningfully improve their loved one’s life. Qualitative research on patient and caregiver preferences has found that most patients in practice rely heavily on their physician’s recommendation rather than expressing strong independent preferences about device type or approach.¹⁸ This places an extra responsibility on clinicians to present realistic expectations clearly.

One thing families should understand is that a pacemaker does not prevent dementia, cancer, or the general trajectory of aging. The same population-based study that found 75% symptom improvement also noted that about a third of patients experienced worsening or new dementia during follow-up, and a quarter developed orthopedic disability.¹⁰ The pacemaker fixed the heart rhythm problem; it did not stop the clock. Setting expectations appropriately before the procedure helps both the patient and the family adjust to what life afterward will realistically look like.

Thinking About Deactivation Before Implantation

This is a conversation most people would rather skip, but it matters more at 90 than at 60. Professional society guidelines recommend that discussions about potential future device deactivation be included in the pre-implantation consent process, not deferred until the patient is actively dying.¹⁹ In practice, these conversations are infrequent, which can create confusion and distress when the end of life does arrive.

A pacemaker can be deactivated at any time if a patient or their designated surrogate requests it. Current guidelines affirm that this is both ethically and legally permissible.¹⁹ For someone who is pacemaker-dependent, meaning their heart cannot maintain an adequate rhythm without the device, deactivation would likely hasten death. For someone who only paces intermittently, turning it off may have minimal immediate effect. Either way, knowing the plan ahead of time spares families from making agonizing decisions in a crisis. Discussing this before implantation also gives the patient a voice in their own care at a time when they are lucid and capable of weighing the options.²⁰

Remote Monitoring After Implantation

Getting a 90-year-old to the cardiologist’s office every few months for device checks is a real burden, especially for those with mobility problems or who live far from a clinic. Remote monitoring systems allow the pacemaker to transmit data to the cardiology team from the patient’s home. Studies have found that remote monitoring is just as reliable as in-clinic follow-up for detecting problems, and that even elderly patients and their families manage the transmission equipment without much difficulty.²¹

Research specifically looking at debilitated elderly pacemaker patients found that remote follow-up was well accepted, required minimal technical support, and reduced costs for both the healthcare system and the families themselves. Requests for nursing help were rare, and technical communication problems were limited to occasional phone-line issues.²² For a frail 90-year-old, the ability to skip most clinic visits without sacrificing safety can be a significant quality-of-life benefit on top of the pacemaker itself.

When a Pacemaker Probably Is Not Worth It

The evidence consistently shows that age alone should not rule out pacemaker implantation. But certain combinations of conditions tip the calculus. A patient with advanced dementia who is no longer aware of their symptoms, active widespread cancer with a life expectancy measured in weeks, or severe multi-organ failure is unlikely to benefit meaningfully. The strongest mortality predictors identified in nonagenarian studies, such as active oncological disease, neurological disease, and severe kidney impairment, are signals that the expected benefit window may be too narrow to justify even a low-risk procedure.⁸

Geriatric cardiology experts increasingly advocate for integrating domains like frailty, functional status, and cognition into the decision rather than relying solely on the cardiac indication.²³ A 90-year-old who walks independently, recognizes family, and is bothered by daily dizziness is a fundamentally different candidate than a bedbound 90-year-old with end-stage kidney disease. The first person stands to regain comfort and avoid dangerous falls. The second may gain nothing perceptible.

Pocket Infections and Late Complications

One long-term concern specific to very old patients is infection of the pacemaker pocket, the small pouch under the skin where the generator sits. These infections sometimes require removing the entire system, including leads that may have been in place for years and become embedded in scar tissue. In frail elderly patients with multiple medical problems, that extraction carries meaningful risk. Even experienced electrophysiologists sometimes look for alternatives to lead extraction in this group, especially when the infection is localized and without systemic spread.²⁴

Leadless pacemakers sidestep this problem entirely by eliminating the pocket. For patients with dementia who might pick at their chest incision or very thin patients whose skin could erode over the generator, the intracardiac leadless device removes the risk of pocket trouble altogether.¹⁴ This advantage becomes more relevant with each passing year after implantation, making device choice at the outset particularly important for patients expected to live several more years.

1
PubMed Central. Pacemaker therapy in very elderly patients: survival and prognostic parameters of single center experience
2
PubMed Central. Pace Maker Implantation for Elderly Individuals Over 90 Years Old
3
PubMed. Safety of pacemaker implantation in nonagenarians: an analysis of the healthcare cost and utilization project-nationwide inpatient sample
4
PubMed. Pacemaker implantation in the extreme elderly
5
PubMed. Long-term prognosis of patients older than ninety years after permanent pacemaker implantation: does the procedure save the patients?
6
PubMed. Significant and safe reduction of propofol sedation dose for geriatric population undergoing pacemaker implantation: randomized clinical trial
7
European Heart Journal Supplements. P14 PROCEDURAL SAFETY, SHORT AND LONG–TERM FOLLOW UP AFTER PACEMAKER IMPLANTATION IN NONAGENARIANS
8
Journal of Cardiovascular Medicine. Short- and long-term survival in patients over 90 years old undergoing pacemaker implantation
9
Age and Ageing. EMERGENCY PACEMAKER IMPLANTATION IN NONAGENARIANS: IMPACT OF FRAILTY ON OPERATOR DECISION-MAKING AND PATIENT OUTCOMES
10
PubMed. Survival and functional independence after implantation of a permanent pacemaker in octogenarians and nonagenarians. A population-based study
11
PubMed Central. Falls and fractures in the elderly with sinus node disease: the impact of pacemaker implantation
12
EP Europace. Reduction of falls and fractures after permanent pacemaker implantation in elderly patients with sinus node dysfunction
13
European Heart Journal. Gender differences in nonagenarians undergoing pacemaker implantation
14
PubMed Central. Leadless cardiac pacemaker implantations after infected pacemaker system removals in octogenarians
15
PubMed. Safety of leadless pacemaker implantation in the very elderly
16
Revista Española de Cardiología (English Edition). Performance of the Micra cardiac pacemaker in nonagenarians
17
PubMed Central. Utilizing Leadless Pacemakers in Extremely Elderly Patients With a Conventional Pacemaker System: A Two-Year Follow-Up Case Series Without Generator Extraction in High-Risk Scenarios
18
The Patient – Patient-Centered Outcomes Research. Patients’ Needs and Preferences for Cardiac Pacemaker Implantation: A Qualitative Study on Disease and Medical Device Characteristics to Inform a Quantitative Preference Study
19
PubMed. Deactivation of Cardiac Devices at the End of Life: Clinical and Ethical Challenges
20
PubMed Central. Practical and ethical considerations in the management of pacemaker and implantable cardiac defibrillator devices in terminally ill patients
21
PubMed Central. Advances in telemedicine for the management of the elderly cardiac patient
22
EP Europace. Remote follow-up of pacemakers in a selected population of debilitated elderly patients
23
PubMed Central. Cardiac resynchronization therapy in very old patients with pacemakers: a cardiogeriatric, physiology-based approach
24
EP Europace. Conservative treatment of pacemaker pocket infection: is it a viable option?